Politics John Wilkerson STAT Plus: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
Pharmalot Ed Silverman STAT Plus: White House is told the big three PBMs are ‘everything wrong with this industry’
Politics Rachel Cohrs Zhang STAT Plus: White House touts incremental step in Medicare drug price negotiation: counteroffers
Politics John Wilkerson STAT Plus: What does America’s crackdown on Chinese firms mean for the U.S. biotech sector?
Exclusive Ed Silverman STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers
Politics Nicholas Florko STAT Plus: Why won’t Medicare deliver food to sick seniors, if it could get them healthy?
First Opinion Lawrence K. Altman STAT Plus: I’ve reported on the health of every president since Reagan. Here’s what I think about Trump and Biden
Politics Rachel Cohrs Zhang STAT Plus: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
Exclusive Helen Branswell STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel
Politics Rachel Cohrs Zhang STAT Plus: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices
Politics John Wilkerson STAT Plus: Judge skeptical of arguments against Medicare drug price negotiation
Politics Sarah Owermohle STAT Plus: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next
Politics Sarah Owermohle Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in
The Readout Damian Garde STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect